Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Campath-1H Induction in Pediatric Renal Transplant
NCT00167661Phase 2Terminated
- Sponsor
- University of Wisconsin–Madison
- Start
- Jun 2004
- Primary completion
- Dec 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of alemtuzumab in kidney transplant rejection, sponsored by University of Wisconsin–Madison. Started Jun 2004; status: terminated.
02
Drugs
alemtuzumab
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00167661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00167661.